WebINCB053914 (INCB-053914) is a novel potent, and selective ATP-competitive, pan-PIM kinase inhibitor with IC50 of 0.24/30.0/0.12 nM for PIM1/2/3, respectively; INCB053914 is highly selective against a panel of more than 50 kinases (>475-fold selectivity) with exception of RSK2 (IC50=7.1 uM); inhibits cellular proliferation in a panel of cell lines … WebINCB053914 inhibits phosphorylation of PIM substrates and increases PIM2 expression in primary bone marrow (BM) blasts (A), and increases PIM2 expression in PBMCs derived from whole blood samples from patients with AML (B). Pharmacodynamic effects of INCB053914 on PIM2 expression and 4E-BP1 phosphorylation in whole blood samples …
33 U.S. Code § 3914 - Requirements U.S. Code US Law LII / …
Uzansertib (INCB053914) is a novel, ATP-competitive, small molecule, pan-inhibitor of PIM kinases with IC50 values of 0.24 nM, 30 nM and 0.12 nM for PIM1, PIM2 and PIM3 respectively in biochemical assays. CAS No. 2088852-47-3 Selleck's Uzansertib (INCB053914) has been cited by 2 Publications Cancer Lett,2024476:23-33 WebINCB053914; INCB-053914; INCB 053914.;Unknown. Molecular Formula: C20H16FN7OS. Cat No: I007297: IC50: 300 nM: Storage: 0 - 4°C for short term , or -20°C for long term. Recommended degree::-15: Price: Get quote: We would like to match the lowest price on market if possible. For research use only. Not Intended for Therapeutic Use! tpg sherman tx
INCB053914 1620012-39-6 RayStarBio.com
WebINCB053914 is a novel, ATP-competitive, small molecule, pan-inhibitor of PIM kinases. INCB053914 is potent against PIM1, PIM2 and PIM3 and highly selective. INCB053914 is active as a single agent in the majority of cell lines derived from different hematological malignancies, including MM, AML, DLBCL, MCL and T-ALL, with IC50 values ranging from … WebSynonyms: INCB 053914, INCB-053914; 2088852-47-3 WebINCB053914 is a novel, potent, and selective adenosine triphosphate-competitive pan-PIM kinase inhibitor. In vitro, INCB053914 inhibited proliferation and the phosphorylation of downstream substrates in cell lines from multiple hematologic malignancies. INCB053914, may have therapeutic utility in hematologic malignancies when combined with other … thermo scientific ab-2396